Mighty Auto Parts has organized “Team Mighty,” who will be riding to raise money in the fight to stop diabetes during the Atlanta Tour de Cure on May 30. Participating with a strong sense of purpose and inspiration, Team Mighty will be riding this year in the memory of their coworker Dave Raphael, who passed away suddenly in September 2014. Raphael was so committed when he participated in the 2014 Atlanta Tour de Cure that he earned the rank of “champion,” raising more than $1,000 in donations to fight diabetes.
Headed by Team Captain Carmen Strickland, Team Mighty has grown this year to include three of Raphael’s close friends: Howard Moses, Maurice Rosenbaum and David Rubini, all riding to help honor their friend. “We are committed to ride and raise money in this inspirational event not only because 29 million people in the United States have diabetes, but because we personally know some of them and want to do something about it,” said Strickland.
Team Mighty would like to thank the following individuals and businesses supporting their efforts this year in the Atlanta Tour de Cure with donations:
• Lexis Printing & Fulfillment
• Mark Eggen with TSI Supercool
• Royal Purple, LLC
• Mighty Corporate personnel
• Blair Smith – Mighty franchise No. 342
• Sam Southerland – Mighty No. 606
• Dan Westerman – Mighty No. 582
• Heather Lovell – Mighty No. 600
• Steve Milton with Integrated Supply Network Inc.
• Ron Pasquale and Tim Craig with R/T Performance Marketing
• David Walworth and Brad Ragland with REMA TIP TOP
• Charles and Blair Sherwood with Sherwood Marketing Co.
• Karin Helm – Mighty franchise No. 512
• Sharman Lemon – Mighty franchise No. 140
• David Kimball – Mighty franchise No. 200
• Mary Reck – Mighty franchise No. 564
If you would like to make donation supporting Team Mighty’s participation in the 2015 Atlanta Tour de Cure, visit: http://main.diabetes.org/goto/teammighty.
By making a donation, you will be helping the American Diabetes Association provide community-based educational programs, protect the rights of people with diabetes and fund critical research for a cure.